Fullspan Health has launched a unified platform aimed at helping pharmaceutical and healthcare brands engage patients across the full care journey, from initial discovery through to treatment and ongoing adherence.
The new B2B offering brings together media, content, patient engagement and care support into a single ecosystem, drawing on RVO Health’s portfolio, including Healthline Media and Healthgrades, which together reach 63 million people each month.
The launch marks an evolution for Fullspan Health, consolidating its existing direct-to-patient and patient services capabilities into a single, integrated system designed for life sciences and healthcare organisations. The platform is intended to help brands guide patients more seamlessly from awareness and education to clinical action, medication adherence and lifestyle support.
The move reflects a broader industry shift away from fragmented, point-solution approaches toward more continuous, end-to-end models of engagement. As patients increasingly navigate multiple digital touchpoints to research symptoms, explore treatments, find providers and access care, maintaining consistency across that journey has become a growing challenge for brands.
Fullspan Health’s platform is structured across two core components: a media and content offering that connects brands with high-intent audiences, and a solutions suite that integrates tools such as patient navigation, telehealth, pharmacy access and adherence support. The company also highlighted the role of AI-powered tools and integrated data in enabling more coordinated and measurable engagement.
According to the company, its programmes have already supported more than 10 million individuals through wellness and patient engagement initiatives.
Commenting on the launch, Christine Maguire said the platform is designed to address fragmentation in how life sciences companies approach media, content and patient services, bringing these elements together into a single system.
The company added that unifying media, data and technology capabilities is intended to support more coordinated engagement across the patient journey, with a greater emphasis on measurable outcomes at each stage.
Fullspan Health’s move highlights a broader structural trend in healthcare marketing: the transition towards integrated patient ecosystems.
For years, pharma brands have worked across a diverse mix of media, content and support partners to reach and engage patients at different stages of their journey. Platforms like Fullspan Health reflect an evolution of this model, bringing those capabilities together into more connected, continuous experiences that can enhance coordination and improve visibility into outcomes.
What’s notable is the increasing convergence of high-intent media environments—such as Healthline Media and Healthgrades—with downstream services like navigation, telehealth and adherence. This signals a shift from awareness-driven strategies toward models that are accountable for real-world patient action.
As the market evolves, the competitive edge will likely come down to how effectively platforms can connect engagement with outcomes—bridging the gap between digital interaction and actual care delivery.